{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T04:45:29Z","timestamp":1790829929761,"version":"4.1.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,13]],"date-time":"2021-07-13T00:00:00Z","timestamp":1626134400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy - Methods & Clinical Development"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.omtm.2021.06.014","type":"journal-article","created":{"date-parts":[[2021,7,16]],"date-time":"2021-07-16T03:26:02Z","timestamp":1626405962000},"page":"377-387","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"special_numbering":"C","title":["Depletion of high-content CD14+ cells from apheresis products is critical for successful transduction and expansion of CAR T\u00a0cells during large-scale cGMP manufacturing"],"prefix":"10.1016","volume":"22","author":[{"given":"Xiuyan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oriana","family":"Borquez-Ojeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolanta","family":"Stefanski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinrong","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jagrutiben","family":"Chaudhari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keyur","family":"Thummar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingzhu","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling-bo","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paridhi","family":"Gautam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongzeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte","family":"S\u00e9n\u00e9chal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devanjan","family":"Sikder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prasad S.","family":"Adusumilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renier J.","family":"Brentjens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Curran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark B.","family":"Geyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sham","family":"Mailankhody","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roisin","family":"O\u2019Cearbhaill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae H.","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig","family":"Sauter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Slovin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric L.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Rivi\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtm.2021.06.014_bib1","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1016\/j.cell.2017.12.002","article-title":"CD19 CAR T Cells","volume":"171","author":"Sadelain","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.omtm.2021.06.014_bib2","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1056\/NEJMra1706169","article-title":"Chimeric Antigen Receptor Therapy","volume":"379","author":"June","year":"2018","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.omtm.2021.06.014_bib3","doi-asserted-by":"crossref","first-page":"16015","DOI":"10.1038\/mto.2016.15","article-title":"Clinical manufacturing of CAR T\u00a0cells: foundation of a promising therapy","volume":"3","author":"Wang","year":"2016","journal-title":"Mol. Ther. Oncolytics"},{"key":"10.1016\/j.omtm.2021.06.014_bib4","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/CJI.0b013e318194a6e8","article-title":"Manufacturing validation of biologically functional T\u00a0cells targeted to CD19 antigen for autologous adoptive cell therapy","volume":"32","author":"Hollyman","year":"2009","journal-title":"J.\u00a0Immunother."},{"key":"10.1016\/j.omtm.2021.06.014_bib5","doi-asserted-by":"crossref","first-page":"224ra25","DOI":"10.1126\/scitranslmed.3008226","article-title":"Efficacy and toxicity management of 19-28z CAR T\u00a0cell therapy in B cell acute lymphoblastic leukemia","volume":"6","author":"Davila","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.omtm.2021.06.014_bib6","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1080\/10428194.2017.1390237","article-title":"Concurrent therapy of chronic lymphocytic leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia utilizing CD19-targeted CAR T-cells","volume":"59","author":"Geyer","year":"2018","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.omtm.2021.06.014_bib7","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1016\/j.ymthe.2018.05.018","article-title":"Autologous CD19-Targeted CAR T Cells in Patients with Residual CLL following Initial Purine Analog-Based Therapy","volume":"26","author":"Geyer","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2021.06.014_bib8","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1056\/NEJMoa1709919","article-title":"Long-Term Follow-up of CD19 CAR Therapy in Acute Lymphoblastic Leukemia","volume":"378","author":"Park","year":"2018","journal-title":"N.\u00a0Engl. J. Med."},{"issue":"Suppl 1","key":"10.1016\/j.omtm.2021.06.014_bib9","first-page":"S33","article-title":"Targeting Castration Resistant Prostate Cancer (CRPC) with Autologous PSMA-Directed Chimeric Antigen Receptor T Cells","volume":"20","author":"Slovin","year":"2012","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2021.06.014_bib10","doi-asserted-by":"crossref","first-page":"e994446","DOI":"10.4161\/2162402X.2014.994446","article-title":"IL-12 secreting tumor-targeted chimeric antigen receptor T\u00a0cells eradicate ovarian tumors in\u00a0vivo","volume":"4","author":"Koneru","year":"2015","journal-title":"OncoImmunology"},{"key":"10.1016\/j.omtm.2021.06.014_bib11","doi-asserted-by":"crossref","first-page":"261ra151","DOI":"10.1126\/scitranslmed.3010162","article-title":"Regional delivery of mesothelin-targeted CAR T\u00a0cell therapy generates potent and long-lasting CD4-dependent tumor immunity","volume":"6","author":"Adusumilli","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.omtm.2021.06.014_bib12","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1016\/j.ymthe.2018.03.016","article-title":"Development and Evaluation of an Optimal Human Single-Chain Variable Fragment-Derived BCMA-Targeted CAR T Cell Vector","volume":"26","author":"Smith","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2021.06.014_bib13","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1080\/10428194.2017.1393668","article-title":"CAR T\u00a0cell therapy for multiple myeloma: where are we now and where are we headed?","volume":"59","author":"Ghosh","year":"2018","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.omtm.2021.06.014_bib14","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1182\/blood.2019001641","article-title":"Toxicity and response after CD19-specific CAR T-cell therapy in pediatric\/young adult relapsed\/refractory B-ALL","volume":"134","author":"Curran","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2021.06.014_bib15","doi-asserted-by":"crossref","first-page":"e122627","DOI":"10.1172\/jci.insight.122627","article-title":"Safety and tolerability of conditioning chemotherapy followed by CD19-targeted CAR T\u00a0cells for relapsed\/refractory CLL","volume":"5","author":"Geyer","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.omtm.2021.06.014_bib16","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1182\/blood.2018883421","article-title":"CD19 CAR T\u00a0cells following autologous transplantation in poor-risk relapsed and refractory B-cell non-Hodgkin lymphoma","volume":"134","author":"Sauter","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2021.06.014_bib17","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1189\/jlb.0806510","article-title":"The CD14+ CD16+ blood monocytes: their role in infection and inflammation","volume":"81","author":"Ziegler-Heitbrock","year":"2007","journal-title":"J.\u00a0Leukoc. Biol."},{"key":"10.1016\/j.omtm.2021.06.014_bib18","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1182\/blood.V74.7.2527.2527","article-title":"Identification and characterization of a novel monocyte subpopulation in human peripheral blood","volume":"74","author":"Passlick","year":"1989","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2021.06.014_bib19","doi-asserted-by":"crossref","first-page":"423","DOI":"10.3389\/fimmu.2015.00423","article-title":"Blood Monocytes and Their Subsets: Established Features and Open Questions","volume":"6","author":"Ziegler-Heitbrock","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omtm.2021.06.014_bib20","series-title":"The Impact of Food Bioactives on Health: in vitro and ex vivo models [Internet]","first-page":"161","article-title":"Peripheral Blood Mononuclear Cells","author":"Kleiveland","year":"2015"},{"issue":"Suppl 1","key":"10.1016\/j.omtm.2021.06.014_bib21","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1016\/S1525-0016(16)33685-1","article-title":"Depletion of High-Content CD14+ Cells from Apheresis Products is Critical for the Successful Transduction and Expansion of CAR T Cells During Large-Scale cGMP Manufacturing","volume":"23","author":"Wang","year":"2015","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2021.06.014_bib22","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s13045-019-0797-3","article-title":"Myeloid-derived suppressor cells in hematological malignancies: friends or foes","volume":"12","author":"Lv","year":"2019","journal-title":"J.\u00a0Hematol. Oncol."},{"key":"10.1016\/j.omtm.2021.06.014_bib23","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.bbmt.2018.10.004","article-title":"Manufacture of Chimeric Antigen Receptor T Cells from Mobilized Cyropreserved Peripheral Blood Stem Cell Units Depends on Monocyte Depletion","volume":"25","author":"K\u00fcnkele","year":"2019","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.omtm.2021.06.014_bib24","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s12967-017-1160-5","article-title":"Elutriated lymphocytes for manufacturing chimeric antigen receptor T\u00a0cells","volume":"15","author":"Stroncek","year":"2017","journal-title":"J.\u00a0Transl. Med."},{"key":"10.1016\/j.omtm.2021.06.014_bib25","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.jcyt.2016.04.003","article-title":"Myeloid cells in peripheral blood mononuclear cell concentrates inhibit the expansion of chimeric antigen receptor T\u00a0cells","volume":"18","author":"Stroncek","year":"2016","journal-title":"Cytotherapy"},{"key":"10.1016\/j.omtm.2021.06.014_bib26","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.omtm.2021.02.002","article-title":"Enriching leukapheresis improves T\u00a0cell activation and transduction efficiency during CAR T processing","volume":"20","author":"Noaks","year":"2021","journal-title":"Mol. Ther. Methods Clin. Dev."},{"issue":"Suppl 1","key":"10.1016\/j.omtm.2021.06.014_bib27","doi-asserted-by":"crossref","first-page":"170.3","DOI":"10.4049\/jimmunol.204.Supp.170.3","article-title":"Optimization of CAR T\u00a0cell co-stimulation reduces to MDSC suppression","volume":"204","author":"Boucher","year":"2020","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.omtm.2021.06.014_bib28","doi-asserted-by":"crossref","first-page":"e000706","DOI":"10.1136\/jitc-2020-000706","article-title":"Adherent cell depletion promotes the expansion of renal cell carcinoma infiltrating T\u00a0cells with optimal characteristics for adoptive transfer","volume":"8","author":"Braun","year":"2020","journal-title":"J.\u00a0Immunother. Cancer"},{"key":"10.1016\/j.omtm.2021.06.014_bib29","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1182\/blood.V92.1.215.413k10_215_222","article-title":"Production of interleukin-10 by granulocyte colony-stimulating factor-mobilized blood products: a mechanism for monocyte-mediated suppression of T-cell proliferation","volume":"92","author":"Mielcarek","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2021.06.014_bib30","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1200\/JCO.19.03279","article-title":"CD4\/CD8 T-Cell Selection Affects Chimeric Antigen Receptor (CAR) T-Cell Potency and Toxicity: Updated Results From a Phase I Anti-CD22 CAR T-Cell Trial","volume":"38","author":"Shah","year":"2020","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.omtm.2021.06.014_bib31","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0022-1759(90)90256-U","article-title":"Detection of surface and cytoplasmic CD4 on blood monocytes from normal and HIV-1 infected individuals","volume":"135","author":"Filion","year":"1990","journal-title":"J.\u00a0Immunol. Methods"}],"container-title":["Molecular Therapy - Methods & Clinical Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050121001169?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050121001169?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T09:28:01Z","timestamp":1762421281000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2329050121001169"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":31,"alternative-id":["S2329050121001169"],"URL":"https:\/\/doi.org\/10.1016\/j.omtm.2021.06.014","relation":{},"ISSN":["2329-0501"],"issn-type":[{"value":"2329-0501","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Depletion of high-content CD14+ cells from apheresis products is critical for successful transduction and expansion of CAR T\u00a0cells during large-scale cGMP manufacturing","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy - Methods & Clinical Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtm.2021.06.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021","name":"copyright","label":"Copyright"}]}}